Rare diseases
Investigational molecules
Locations
213 conditions with trials, the busiest first
504 trials across Europe, recruiting first
Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyA study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes
PolandA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
FranceA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
AustriaStudy of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes
CzechiaStudy on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes
BulgariaStudy on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs
GreeceStudy on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss
GermanyStudy on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches
DenmarkStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
AustriaEfficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial
DenmarkEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
AustriaThe therapies tested most often in Endocrine disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
